| Title : Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis - Guadalupi_2024_Neuropharmacol__109940 |
| Author(s) : Guadalupi L , Mandolesi G , Vanni V , Balletta S , Caioli S , Pavlovic A , De Vito F , Fresegna D , Sanna K , Vitiello L , Nencini M , Tartacca A , Mariani F , Rovella V , Schippling S , Ruf I , Collin L , Centonze D , Musella A |
| Ref : Neuropharmacology , :109940 , 2024 |
| Abstract : Guadalupi_2024_Neuropharmacol__109940 |
| ESTHER : Guadalupi_2024_Neuropharmacol__109940 |
| PubMedSearch : Guadalupi_2024_Neuropharmacol__109940 |
| PubMedID: 38570068 |
Guadalupi L, Mandolesi G, Vanni V, Balletta S, Caioli S, Pavlovic A, De Vito F, Fresegna D, Sanna K, Vitiello L, Nencini M, Tartacca A, Mariani F, Rovella V, Schippling S, Ruf I, Collin L, Centonze D, Musella A (2024)
Pharmacological blockade of 2-AG degradation ameliorates clinical, neuroinflammatory and synaptic alterations in experimental autoimmune encephalomyelitis
Neuropharmacology
:109940
Guadalupi L, Mandolesi G, Vanni V, Balletta S, Caioli S, Pavlovic A, De Vito F, Fresegna D, Sanna K, Vitiello L, Nencini M, Tartacca A, Mariani F, Rovella V, Schippling S, Ruf I, Collin L, Centonze D, Musella A (2024)
Neuropharmacology
:109940